INTRODUCTION {#SEC1}
============

Chromosome segregation during cell division and differentiation is a fundamental cellular process in both prokaryotes and eukaryotes ([@B1]). Abnormal chromosome segregation induces genetic mutations and causes diverse disorders in humans, such as Down syndrome and Turner syndrome ([@B4]). Unlike the corresponding eukaryotic process, chromosome segregation in bacteria is a process during which chromosomes are separated rapidly as they are being replicated ([@B5]). Defects in the chromosome segregation system in bacteria result in abnormal cells that have no nucleoids or multiple nucleoids ([@B6]). In the model bacterium *Caulobacter crescentus*, depletion of the chromosome segregation protein blocks septum formation and affects cell viability ([@B7]). In *Corynebacterium glutamicum* and *Bacillus subtilis*, strains with deletions of genes encoding partitioning proteins are still viable but show increased anucleate cells and reduced growth rate ([@B8]).

Chromosome segregation in most bacteria (e.g. *C. crescentus*, *B. subtilis* and *Mycobacterium smegmatis* but not *Escherichia coli*) is mediated by ParA--ParB--*parS* or homologous systems ([@B8]). The ParA-ParB-*parS* system consists of an ATPase (ParA), a DNA-binding protein (ParB), and a cluster of centromeric DNA sequences (*parS*). In bacteria, *parS* is usually located adjacent to the chromosomal replication region (*oriC*) ([@B10]). During chromosome segregation, ParB binds to *parS* and the nearby sequence to generate a compact nucleoprotein complex that can further bind to the ParA subunits and stimulate ParA ATP hydrolysis. Consequently, the ParB--*parS* segregation complex follows a moving gradient of ATP-bound ParA in a Brownian ratchet mechanism that ultimately redistributes the *oriC* regions so that they flank cell division septa ([@B12],[@B13]).

As a representative member of actinomycetes, *Streptomyces coelicolor* is known for its ability to differentiate and produce secondary metabolites ([@B14]). During chromosome segregation in *S. coelicolor*, multiple ParB molecules bind to more than 20 *parS* sites to form a massive nucleoprotein complex around *oriC* ([@B15]). Knocking out the *parB* coding sequence in *S. coelicolor* does not visibly affect cell growth but results in unevenly sized or anucleate spores ([@B16]). Hence, the formation of ParB complex foci in sporulating aerial hyphae is critical for proper chromosome segregation ([@B16]). While the transcriptional regulation of *parAB* is documented ([@B18]), no post-translational regulation has been reported for ParB.

Lysine acetylation (Figure [1A](#F1){ref-type="fig"}) is a reversible post-translational modification (PTM) that was shown to regulate diverse cellular processes widespread in organisms from *E. coli* to humans ([@B19]). In *E. coli* and *Salmonella enterica*, a wide variety of acetylation proteins enriched in central metabolism were reported ([@B23]). Acetylation alters the charge of lysine residues and changes protein structures, thereby affecting enzyme activity, DNA-binding affinity, or protein stability ([@B26],[@B27]). In contrast to transcriptional regulation, PTMs such as acetylation usually fine-tune the activities of proteins rather than turn them on or off ([@B28],[@B29]). In *Streptomyces lividans*, the activity of acetoacetyl-CoA synthetase was reported to be repressed by acetylation ([@B30]). Nevertheless, the understanding of acetylation regulation of prokaryotic cellular processes remains at an early stage.

![Identification of the chromosome partitioning protein ParB as an acetylation target in *S. coelicolor*. (**A**) Chemical structures of a lysine residue and an acetylated lysine. The corresponding substrates and the products of acetylation or deacetylation are shown. (**B**) Schematic representation of the *S. coelicolor* life cycle. *S. coelicolor* vegetative hyphae germinate from a single spore. They branch and develop into aerial filaments based on nutrient availability and other environmental signals. Aerial hyphae develop after ∼2 days of culture and then turn into spore chains. The life cycle restarts after the spores are mature and dispersed. Corresponding phenotypes (I--IV) of *S. coelicolor* on MS solid medium are shown as an example. (**C**) Analysis of the ParB acetylation level throughout the *S. coelicolor* cell cycle on MS solid culture. The His-tagged ParB proteins were isolated from the *S. coelicolor* PL138 strain at different time points (24, 36, 48, 60 and 84 h) and then quantified by western blotting. Their relative acetylation levels were normalized to the loading protein levels (see Materials and Methods). The results show that the ParB acetylation level was decreased after 48-h cultivation, which is at a growth phase that cultures are composed of both vegetative hyphae and white aerial hyphae (corresponding to growth phenotype III in Figure [1B](#F1){ref-type="fig"}). Similar growth curves were monitored between PL138 and wild-type *S. coelicolor* (upper right panel), ruling out possible impacts of the labelled ParB on cell growth. One representative result of triplicate measurements is shown. HPLC/MS-MS analysis identified Lys-183 (**D**) as one of the two ParB acetylation sites. The ParB protein was isolated from *S. coelicolor* after a 36-h cultivation and then digested and subjected to HPLC/MS-MS analyses.](gkaa245fig1){#F1}

In *S. coelicolor*, a previous *in vitro* study showed that SCO0452 exhibits deacetylase activity and deacetylates acetyl-CoA synthetase ([@B31]). By in-frame deletion of *SCO0452*, our preliminary results showed that Δ*SCO0452* generated a few unevenly sized spores ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). Further comparative acetylome analyses (unpublished data) found that among the cell development proteins, the chromosome segregation protein ParB is acetylation enriched in Δ*SCO0452* cells. In this study, we confirmed that ParB is acetylated at Lys-183, which is regulated by the deacetylase SCO0452. Deacetylation of ParB enhances its binding affinity to the *parS* DNA sequences, while acetylation of ParB decreases the binding activity. By applying genetics and biochemical approaches, we observed that dysfunction in ParB acetylation results in the disturbance of segregation complex formation, which may lead to sporulation defects in *S. coelicolor*.

MATERIALS AND METHODS {#SEC2}
=====================

Materials {#SEC2-1}
---------

All strains ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}), plasmids ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}), primers ([Supplementary Table S3](#sup1){ref-type="supplementary-material"}), and culture media used in this study are listed in the Supplemental Information. The pan anti-acetyllysine antibody used in this study was the same as that described in ([@B23]), and the anti-His-tag antibody was purchased from Abmart, Shanghai, China.

Determining the acetylation level of endogenous ParB in *S. coelicolor* {#SEC2-2}
-----------------------------------------------------------------------

To determine the endogenous ParB acetylation level during various growth phases, the *S. coelicolor* PL138 strain \[*SCO3887*::*parB-his-aac(3)IV*\] was generated to express a His-tagged ParB by replacing the *parB* gene (*SCO3887*) with *parB-his-aac(3)IV* in the wild-type *S. coelicolor* chromosome (see Supplemental Information for details). Fresh spore suspension of PL138 was diluted to an OD600 of 1.5 and pre-germinated in TSB (tryptic soy broth) liquid medium at 50°C for 10 min. Five hundred microliters of spores were plated and grown on one MS (Mannitol Soya Flour) agar plate at 30°C. The MS plates (diameter: 150 mm) were covered with sterile plastic cellophane before spore plating. Cells were harvested from the MS plate using a bamboo scraper at the indicated time points (24, 30, 36, 48, 60, 72 and 84 h). One sample cell from each plate was collected for either the growth curve measurement or the endogenous ParB acetylation determination.

To determine the acetylation level of endogenous ParB, the samples were resuspended in cold Tris--HCl buffer (50 mM, pH 8.0) that contained NaCl (500 mM), imidazole (10 mM), EDTA (1 mM) and phenylmethanesulfonyl fluoride (PMSF, 1 mM) and were lysed using an EmulsiFlex-C5 cell disruptor (Avestin, Inc., Ottawa, Canada). The collected supernatants were loaded onto a 5-ml nickel resin column (GE Healthcare, USA) and purified with the ÄKTA™ FPLC System. After washing with buffer (50 mM Tris--HCl, 500 mM NaCl and 20 mM imidazole, pH 8.0), ParB proteins were obtained by elution from the system (elution buffer: 50 mM Tris--HCl, 500 mM NaCl and 500 mM imidazole, pH 8.0), resulting in \>90% purity. To quantify the acetylation level of endogenous ParB, western blotting was performed using a pan anti-acetyl lysine antibody ([@B23]) for these ParB-His proteins. An anti-His (monoclonal antibody, Abmart, [Supplementary Figure S14](#sup1){ref-type="supplementary-material"}) western blot was employed as a loading control.

Determining ParB acetylation sites by mass spectrometry {#SEC2-3}
-------------------------------------------------------

The endogenous ParB acetylation sites were identified using protein purified from *S. coelicolor* PL138 after a 36-h cultivation in TSB medium. The purified ParB was digested by trypsin, and the corresponding peptides were analysed by nano-high-performance liquid chromatography (nano-HPLC)-tandem mass spectrometry (MS/MS) using an Agilent 1100 nanoflow system connected to a Q Exactive hybrid quadrupole-orbitrap mass spectrometer (Thermo Finnigan, CA, USA). The peptides were separated prior to mass spectral analysis using a C18 reversed-phase HPLC trap column (Zorbax 300SB-C18; 5.0 μm; 5.0 × 0.3 mm; Agilent). Solvent A was 0.1% (v/v) formic acid in water, while solvent B was 0.1% (v/v) formic acid in 84% (v/v) acetonitrile. The chromatographic gradient was as follows: 50 min for 4--50% (v/v) solvent B followed by 5 min for 50--100% (v/v) solvent B. The peptides eluted from the HPLC column/electrospray source were subjected to MS survey scans. Raw MS/MS data were used to search a user-defined amino acid sequence database with the Mascot 2.2 program. Cysteine carbamidomethylation was used as a fixed modification, while lysine acetylation and methionine oxidation were set as the variable modifications.

*In vitro* acetylation and deacetylation of ParB {#SEC2-4}
------------------------------------------------

The *in vitro* acetylation of ParB was performed at 30°C for 2 h in a 50-μl reaction mixture containing 50 mM Tris--HCl (pH 8.0), 0.55 μM ParB or ParB variants, 0.35 μM *Sc*Pat, and 0.2 mM acetyl-CoA. For the acetyl phosphate (AcP)-mediated acetylation reaction, a 50-μl mixture containing 50 mM Tris--HCl (pH 8.0) and 0.55 μM ParB or ParB variants with 1.0--3.0 mM AcP was incubated at 30°C for 2 h.

The *in vitro* deacetylation was performed at 30°C for 2 h in a 50-μl reaction mixture containing 50 mM Tris--HCl (pH 8.0), 6.0 mM MgCl~2~, 0.55 μM ParB or ParB variants, 1.2 μM *Sc*CobB1 or 1.5 μM *Sc*CobB2, and 1.0 mM NAD^+^.

The acetylated and deacetylated proteins were then analyzed in an electrophoretic mobility shift assay (EMSA) or a western blot assay.

ParB-*parS* electrophoretic mobility shift assay (EMSA) {#SEC2-5}
-------------------------------------------------------

A labelled *parS* probe containing two consecutive *parS* sequences was amplified from *S. coelicolor* genomic DNA using oligos with fluorescein amidite (FAM) attached at the 5′ end. The purified probe (50 ng) was then incubated with ParB or ParB variants at 30°C for 20 min in a 20-μl reaction mixture containing 50 mM Tris--HCl (pH 8.0), 25 mM KCl, 2.5 mM MgCl~2~, 1.0 mM DTT and 2.0 μg salmon sperm DNA. The mixtures were separated by 5% polyacrylamide gel electrophoresis and analysed with an ImageQuant LAS 4000 mini biomolecular imager (GE Healthcare, USA).

To quantify the ParB--*parS* interaction, the binding constant (*K*~D~) was determined using the same reaction system as above. ParB was treated with *Sc*Pat, *Sc*CobB1 or *Sc*CobB2 before the ParB--*parS* incubation, and ParB without any treatment was used as the control. Specifically, the *parS* probe (12.5 nM) was titrated with a series of different ParB proteins (0, 7, 14, 21, 28, 42, 56, 84, 112 nM). The fraction of probe bound was determined from the background-subtracted signal intensities in gels and calculated as bound/(bound + unbound). The data (fraction bound) in each reaction were plotted versus the concentration of ParB, and the results were fitted with a non-linear regression to the Hill equation in Prism 7 (GraphPad Software, CA, USA).

Analysing the acetylation or deacetylation of peptides by HPLC {#SEC2-6}
--------------------------------------------------------------

Acetylated and non-acetylated peptides containing Lys-183 were synthesized by Guotai Inc. (Hefei, China). Two arginine residues were added to the C-terminus to ensure that the peptides were soluble in water (ParB^K183Ac^, TLRLLK^Ac^LSPRR; ParB^K183^, TLRLLKLSPRR). The peptides were subjected to *in vitro* acetylation or deacetylation treatment as stated in the Supplemental Information and then analysed *via* HPLC using an Aeris peptide XB-C18 column (150 × 4.6 mm, 3.6 μm; Phenomenex, USA). The mobile phase consisted of solvent A (0.1% TFA in HPLC-grade H~2~O) and solvent B (0.1% TFA in HPLC-grade acetonitrile). Peptides were eluted in a linear gradient of 0--80% solvent B at 1 ml min^−1^ over 15 min. The column temperature was set at 25°C, and the peptides were monitored with UV light (215 nm).

Construction of Δ*parB*, Δ*Scpat*, Δ*SccobB1* and Δ*SccobB2 S. coelicolor* mutants {#SEC2-7}
----------------------------------------------------------------------------------

Monogenic *S. coelicolor* mutants (Δ*parB*, Δ*Scpat*, Δ*SccobB1* and Δ*SccobB2*) were generated using a PCR-based gene targeting method ([@B32]). Briefly, the target genes within cosmids were replaced in frame by an apramycin or kanamycin resistance cassette flanked by FLP recognition target (FRT) sites. Then, the resulting cosmids were propagated into *S. coelicolor* cells to induce a double exchange by homologous recombination. *S. coelicolor* clones in which the target gene was deleted were selected by flooding plates containing solid medium with apramycin (50 μg ml^−1^) or kanamycin (100 μg ml^−1^) for 16 h. The putatively positive clones were verified by PCR.

Confocal fluorescence microscopy {#SEC2-8}
--------------------------------

To monitor the formation of the ParB segregation complex, integrative plasmids were constructed and introduced into Δ*parB*, Δ*Scpat*, Δ*SccobB1* and Δ*SccobB2* strains to generate fluorescent ParB-eGFP fusion proteins or variants (see Supplemental Information). Transgenic strains harboring fluorescent ParB or ParB variants were inoculated on MS agar with inserted coverslips. Samples were collected at the indicated times and fixed with a paraformaldehyde/glutaraldehyde mixture for 15 min. Then, samples were washed with PBS buffer and digested with 1 mg ml^−1^ lysozyme for 2 min. After another round of PBS wash, samples were blocked with 2% BSA for 10 min. For cell wall staining, samples were incubated with 10 μg ml^−1^ WGA-Texas red (Molecular Probes, USA) for 10 min; for DNA staining, samples were incubated with 1 μg ml^−1^ DAPI (Sigma-Aldrich, USA) for 10 min. After washing with PBS buffer, the samples were placed in antifade solution (Beyotime, Shanghai) and observed using a Leica TCS SP8 STED confocal microscope equipped with a 100× objective lens. The corresponding green filter sets (excitation and emission wavelengths of 488/20 and 530/20 nm, respectively) for eGFP observation and the red filter sets (excitation and emission wavelengths of 595/5 and 615/10 nm, respectively) for cell wall observation were used in this study. For the detection of chromosomes with DAPI staining, cells were observed using the corresponding DAPI filter sets (excitation and emission wavelengths of 380/30 and 460/50 nm, respectively).

Statistics {#SEC2-9}
----------

The results in the figures are displayed as the mean ± S.D. Comparisons between groups were made by unpaired two-tailed Student\'s t-test. Differences were considered statistically significant if the *P-*value was smaller than 0.05. Significance was indicated as \**P* ≤ 0.05; \*\*\**P* ≤ 0.001; ns, *P* \> 0.05, no significance.

RESULTS {#SEC3}
=======

Identification of ParB as an acetylation target in *S. coelicolor* {#SEC3-1}
------------------------------------------------------------------

*S. coelicolor* is a model organism for studying bacterial cell development (Figure [1B](#F1){ref-type="fig"}) and secondary metabolite biosynthesis ([@B14]). In this study, we observed that the *S. coelicolor* chromosome segregation protein ParB is modified by acetylation and that its acetylation level is constantly changing throughout the cell cycle (Figure [1C](#F1){ref-type="fig"}, [Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}). Remarkably, the ParB acetylation level decreased by ∼90% when *S. coelicolor* entered the sporulation phase after a 48-h cultivation (Figure [1C](#F1){ref-type="fig"}), hinting that ParB acetylation may be involved in *S. coelicolor* chromosome partitioning. To further investigate this possibility, ParB was purified from *S. coelicolor* and employed for HPLC--MS/MS analysis. After three rounds of independent analyses, two lysine sites in ParB \[*i.e*. Lys-183 (Figure [1D](#F1){ref-type="fig"}) and Lys-187 ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"})\] were identified with reliable acetylation modification.

Deacetylation increases the binding affinity of ParB to *parS* {#SEC3-2}
--------------------------------------------------------------

Although there are dozens of genes annotated as potential acetyltransferases, only GNAT (GNC5-type *N*-acetyltransferase)-family enzymes ([@B33]) are characterized as protein acetyltransferases in bacteria, e.g. Pat in *S. enterica* ([@B34]). Meanwhile, substantially fewer sirtuin proteins have been reported in prokaryotes than in mammalian cells ([@B35]). The sole copy of sirtuin named CobB was functionally characterized as both deacetylase and desuccinylase in *E. coli* ([@B36]). Collecting all the known lysine acetyltransferase and sirtuin deacetylase sequences as the query database allowed a putative acetyltransferase/deacetylase system to be predicted in the *S. coelicolor* proteome by the BLASTP program. As shown in Figure [2A](#F2){ref-type="fig"}, two putative protein acetyltransferases (SCO5842 and SCO6582) and two putative sirtuin deacetylases (SCO0452 and SCO6464) were identified because they share high similarities with *E. coli* Pat and CobB, respectively. Conserved motif analyses (Figure [2A](#F2){ref-type="fig"}) revealed a GNAT domain in SCO5842 and a sirtuin catalytic domain (SIR2) in both SCO0452 and SCO6464. However, no acetyltransferase domain was found in SCO6582. We therefore designated SCO5842, SCO0452 and SCO6464 as *Sc*Pat, *Sc*CobB1 and *Sc*CobB2, respectively, in this study (Figure [2A](#F2){ref-type="fig"}).

![ParB acetylation is mainly regulated by the sirtuin-like protein *Sc*CobB1. (**A**) Acetyltransferase and deacetylase homologues were identified by bioinformatics analyses in *S. coelicolor*. Their similarities to the *E. coli* acetyltransferase Pat or deacetylase CobB are shown in the right panel. SCO5842 (*Sc*Pat) contains a GNAT domain (orange) and a very large region that is homologous to NDP-forming acyl-CoA synthetase, including a CoA-binding domain (blue), a flavodoxin domain (brown), and an ATP-grasp domain (green). SCO0452 (*Sc*CobB1) and SCO6464 (*Sc*CobB2) contain a conserved SIR2 (light green) domain. The predicted ParA-binding domain is at the N terminus (yellow), and an HTH domain is in the middle (red) of ParB. The amino acid sequence of the HTH motif with a highlighted K183 residue is provided. NA, not available. (**B**) The acetylation of ParB is mainly modulated by *Sc*CobB1. Purified ParB protein was incubated with *Sc*Pat in the presence or absence of acetyl-CoA or treated with *Sc*CobB1/*Sc*CobB2 in the presence or absence of NAD^+^ for 2 h at 30°C. Then, the acetylation level was assessed by western blotting with a pan anti-acetyllysine antibody. The protein was stained with Coomassie blue (CB) and set as the loading control. ParB acetylation was decreased significantly after *Sc*CobB1 treatment (sample 4). One representative result of triplicate measurements is shown. The relative acetylation levels of triplicates were further measured by ImageJ and normalized against the protein level (right panel). The value of the first sample was set as 100%. Mean values with standard deviations are presented.](gkaa245fig2){#F2}

To elucidate the possible acetylation system for ParB, recombinant ParB was treated *in vitro* with *Sc*Pat, *Sc*CobB1 or *Sc*CobB2. Western blot analysis showed that *Sc*Pat treatment slightly increased the ParB acetylation level, while treatment with *Sc*CobB1 but not *Sc*CobB2 decreased the ParB acetylation level (Figure [2B](#F2){ref-type="fig"}). These observations imply that ParB acetylation is regulated by *Sc*CobB1 and *Sc*Pat in some ways. *Sc*CobB2 does not have any significant effect on ParB deacetylation, which is consistent with our recent findings ([@B37]) that *Sc*CobB2 is a specific desuccinylase in *S. coelicolor*. Here, we used *Sc*CobB2 as a negative control in subsequent experiments.

Because ParB is a central member of the ParA-ParB-*parS* system ([@B8]), the acetylation of ParB may affect its ability to bind *parS* sites. To test this hypothesis, an EMSA was conducted to detect the ParB binding affinity changes in different acetylation states. The 'perfect' *parS*, which contains two consecutive *parS* sequences ([@B15]), was chosen as the probe. As shown in Figure [3](#F3){ref-type="fig"}, the ParB binding affinity to *parS* increased when deacetylated by *Sc*CobB1 (Figure [3A](#F3){ref-type="fig"}), while the opposite effect was observed after *Sc*Pat acetylation (Figure [3B](#F3){ref-type="fig"}). Consistent with our expectation, *Sc*CobB2 treatment did not affect the DNA-binding ability of ParB (Figure [3C](#F3){ref-type="fig"}). The binding constants (*K*~D~) were further determined for ParB with different acetylation levels ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). As shown in Figure [3D](#F3){ref-type="fig"}, the *K*~D~ for the ParB control without any treatment was approximately 33.3 nM. However, the binding affinity of ParB treated with the deacetylase *Sc*CobB1 was approximately 4-fold higher than that of ParB treated with the acetyltransferase *Sc*Pat (Figure [3D](#F3){ref-type="fig"}). No significant difference was observed between the *Sc*CobB2-treated ParB and the control. Therefore, these results indicate that the DNA-binding affinity of ParB is positively regulated by *Sc*CobB1 deacetylation *in vitro*.

![Deacetylation enhances the DNA-binding affinity of ParB *in vitro*. (**A**) An EMSA was performed by incubating a FAM-labelled *parS* sequence with varying amounts of ParB proteins that were pre-treated with active or heat-inactivated *Sc*CobB1. Free DNA and DNA--protein complexes (indicated by arrows) were separated by 5% polyacrylamide gel electrophoresis. Compared to heated*-Sc*CobB1-treated ParB, 20 ng (28 nM) deacetylated ParB can efficiently bind to *parS* fragments. The ParB acetylation level induced by active *Sc*CobB1 (lane 1) or heated *Sc*CobB1 (lane 2) was confirmed by western blot (right panel). (**B**) EMSA results of ParB that was pre-treated with active or heat-inactivated *Sc*Pat. (**C**) EMSA results of ParB treated with active or heat-inactivated *Sc*CobB2. (**D**) Quantification of the DNA-binding affinity of ParB treated with *Sc*CobB1, *Sc*Pat, or *Sc*CobB2. The percentages of DNA bound \[bound / (bound + free DNA)\] in each reaction were plotted versus the concentrations of ParB (see [Supplementary Figure S3](#sup1){ref-type="supplementary-material"} for details). The binding constants *K*~D~ were determined by fitting a non-linear regression with the method of specific binding with a Hill slope.](gkaa245fig3){#F3}

We also assessed the possible effects of another acetylation donor, AcP ([@B38]), on ParB. Although ParB was acetylated after AcP treatment (up to 3 mM) for 2 h ([Supplementary Figure S4A](#sup1){ref-type="supplementary-material"}), the binding affinity of ParB to *parS* was unaffected ([Supplementary Figure S4B](#sup1){ref-type="supplementary-material"}). These observations imply that AcP-induced acetylation might not be specific to the lysine site(s) critical to ParB binding activity.

Identification of Lys-183 as a critical acetylation site in ParB {#SEC3-3}
----------------------------------------------------------------

To clarify the regulatory role associated with the acetylation of Lys-183 and Lys-187 in *S. coelicolor* ParB, the two lysine sites were subjected to site-directed mutagenesis. Previous investigations ([@B20],[@B39]) concluded that a Lys to Arg mutation (K to R) retains the positive charge, mimicking a deacetylated lysine, whereas a Lys to Gln mutation (K to Q) abolishes the positive charge, mimicking an acetylated lysine. The corresponding EMSAs were performed to examine the binding affinity of the ParB variants to *parS* DNA (Figure [4](#F4){ref-type="fig"}). Compared with wild-type ParB, the acetylated mimic ParB^K183Q^ exhibited a very low DNA-binding affinity to *parS*, whereas the deacetylated mimic ParB^K183R^ possessed a relatively higher affinity (Figure [4A](#F4){ref-type="fig"}). Both ParB^K187Q^ and ParB^K187R^ showed similar EMSA patterns to wild-type ParB (Figure [4B](#F4){ref-type="fig"}). These results indicate that Lys-183 rather than Lys-187 is responsible for the regulation of ParB DNA-binding activity. The mutagenesis of Lys to Ala (K to A) was further performed to generate ParB^K183A^ and ParB^K187A^. ParB^K183A^ exhibited no DNA-binding affinity, similar to ParB^K183Q^, while ParB^K187A^ displayed similar affinity to wild-type ParB (Figure [4C](#F4){ref-type="fig"}). Protein motif analysis showed that Lys-183 but not Lys-187 is located at the tail end of the helix-turn-helix (HTH) DNA-binding motif of ParB (Figure [2A](#F2){ref-type="fig"}). As previously reported, the HTH motifs in diverse proteins are critical for these proteins to interact with DNA sequences ([@B40],[@B41]). Taken together, these observations strongly suggest that Lys-183 is a critical site for ParB DNA-binding activity.

![The Lys-183 residue is the key acetylation site in ParB. (**A**) Mutation at Lys-183 alters the ParB DNA-binding affinity. An EMSA was performed using purified ParB, ParB^K183Q^, and ParB^K183R^ as described in Figure 3. (**B**) The DNA-binding affinity of ParB was unaffected when Lys-187 was mutated. An EMSA was performed using purified ParB, ParB^K187Q^, and ParB^K187R^. (**C**) A lysine to alanine mutation (K to A) confirmed that Lys-183 but not Lys-187 alters the ParB DNA-binding affinity. An EMSA was completed using purified ParB, ParB^K183A^, and ParB^K187A^. The acetylation levels of ParB variants were determined by western blotting using a pan anti-acetyllysine antibody. The protein samples analysed in (**D**), (**E**) and (**F**) correspond to the ParB variants in (A), (B) and (C), respectively. One representative result of triplicate measurements is shown. The relative acetylation levels of ParB variants were quantified by ImageJ and normalized against their protein levels (right panels). (**G**) The regulation of ParB acetylation at Lys-183 was confirmed by HPLC. ParB peptides with an acetylated or non-acetylated Lys-183 residue were synthesized and incubated with *Sc*Pat, *Sc*CobB1, or *Sc*CobB2 at 30°C for 2 h. Reactions were terminated by the addition of 1% TFA, after which the samples were analysed by HPLC. Arrows indicate the retention time of the standard acetylated and non-acetylated peptides.](gkaa245fig4){#F4}

Compared to that of Lys-187 (Figure [4E](#F4){ref-type="fig"}), mutagenesis at Lys-183 resulted in ParB acetylation level changes (Figure [4D](#F4){ref-type="fig"}, [F](#F4){ref-type="fig"}), indicating that Lys-183 is the pivotal acetylation site in ParB. However, both ParB^K183Q^ and ParB^K183R^ displayed low acetylation levels compared with those of wild-type ParB (Figure [4D](#F4){ref-type="fig"}). The relatively low acetylation level of ParB^K183Q^ may have been because the structural change in ParB^K183Q^ is not fully mimic the acetylation status of ParB, which was unrecognized by the specific antibody.

We also monitored the acetylation changes for these ParB variants in response to different treatments (i.e. *Sc*Pat or *Sc*CobB1 treatment). In contrast to that of wild-type ParB, the acetylation of either ParB^K183Q^ or ParB^K183R^ was barely affected by *Sc*Pat or *Sc*CobB1 treatment ([Supplementary Figure S5A](#sup1){ref-type="supplementary-material"}). Their DNA-binding affinities were also not changed by the treatments ([Supplementary Figure S5B](#sup1){ref-type="supplementary-material"}). These results imply that Lys-183 is the sole site in ParB regulated by the *Sc*Pat/*Sc*CobB1 system.

With synthesized peptides harbouring the Lys-183 residue of ParB, we were able to recapitulate the acetylation/deacetylation reaction of ParB using an HPLC assay. As shown in Figure [4G](#F4){ref-type="fig"}, *Sc*CobB1 reacted with the ParB^K183Ac^ peptide and generated the deacetylated peptide ParB^K183^ in the presence of the cofactor NAD^+^. In contrast, *Sc*Pat acetylated the ParB peptide at the Lys-183 residue and produced a small fraction of ParB^K183Ac^. Meanwhile, *Sc*CobB2 exhibited no deacetylation activity. The peptide was also treated with 3 mM AcP, but the results suggested that the ParB^K183^ peptide cannot be acetylated by AcP ([Supplementary Figure S6](#sup1){ref-type="supplementary-material"}).

ParB is mainly regulated by *Sc*CobB1 deacetylation *in vivo* {#SEC3-4}
-------------------------------------------------------------

To determine whether ParB is regulated by acetylation *in vivo*, we constructed monogenic mutants by in-frame knocking out *Scpat* (Δ*Scpat*), *SccobB1* (Δ*SccobB1*) or *SccobB2* (Δ*SccobB2*) in *S. coelicolor*. Comparison of the whole protein extracts found that the Δ*SccobB1* cells have an obviously increased acetylation level ([Supplementary Figure S7](#sup1){ref-type="supplementary-material"}). Conversely, Δ*Scpat* has a slightly lower acetylation level than the wild-type control ([Supplementary Figure S7](#sup1){ref-type="supplementary-material"}). This observation indicates that the sirtuin-like deacetylase *Sc*CobB1 may play a global regulatory role in *S. coelicolor* acetylation. Similar observations of global regulation by CobB have been reported in *S. enterica* ([@B23]) and *M. smegmatis* ([@B42]).

Based on *S. coelicolor* PL138, we were able to create another two ParB expression strains in the genetic background of Δ*Scpat* or Δ*SccobB1* (see *Materials and Methods*). For simplicity, we named these two strains PL139 and PL140, respectively. To observe the dynamics of ParB acetylation, ParB-His proteins were isolated at different time points (i.e. 24, 48 and 72 h) from PL138, PL139 and PL140 grown in TSB liquid medium and then subjected to western blot analysis (Figure [5](#F5){ref-type="fig"}, [Supplementary Figure S8](#sup1){ref-type="supplementary-material"}). The ParB acetylation level decreased when *S. coelicolor* PL138 entered into the stationary growth phase after a 48-h cultivation in liquid medium (Figure [5](#F5){ref-type="fig"}, samples 1, 4 and 7). These observations indicate that deacetylation may also occur in vegetative hyphae. By comparing the acetylation levels among PL138, PL139 and PL140, we observed a significant difference in PL140 (Δ*SccobB1*) since its ParB acetylation level was sustained and not decreased during the stationary growth phase (Figure [5](#F5){ref-type="fig"}, samples 3, 6 and 9). These results suggest that *Sc*CobB1 plays a major regulatory role in ParB acetylation *in vivo*. In contrast, the regulation of ParB by *Sc*Pat was not significant most of the time, and it may be functional at only the early logarithmic growth phase (Figure [5](#F5){ref-type="fig"}, sample 2).

![The acetylation level of ParB is regulated by *Sc*CobB1 *in vivo*. ParB-His proteins were expressed by replacing the native *parb* with *parb-his-aac(3)IV* in the chromosomes of PL138 (WT), PL139 (Δ*Scpat*), and PL140 (Δ*SccobB1*). Proteins were collected at different time points (i.e. 24 h, 48 h, 72 h) from these cells grown in TSB liquid medium. Their acetylation levels were assessed by western blotting using the pan anti-acetyllysine antibody. Compared to that in the WT strain, the *in vivo* acetylation level of ParB in Δ*SccobB1* was sustained rather than being decreased after 48 h of cultivation. The relative acetylation levels of ParB-His proteins were quantified by ImageJ and normalized against their protein levels, which were determined by the anti-His antibody. The value of the first sample was set as 100%. One representative result of two replicate measurements is shown. Mean values with standard deviations are presented.](gkaa245fig5){#F5}

Deletion of *SccobB1* represses the formation of ParB segregation complexes and leads to cell sporulation defects {#SEC3-5}
-----------------------------------------------------------------------------------------------------------------

Previous studies suggested that mutations in the ParB DNA-binding motif lead to severe chromosome segregation defects ([@B16]). To determine whether the acetylation of ParB affects *S. coelicolor* chromosome segregation, fluorescence microscopy was employed to detect ParB segregation complex formation by labelling ParB with an enhanced GFP protein. The cells were inoculated onto MS solid agar for observation of chromosome segregation and cell division. Similar to previous reports ([@B18]), when wild-type *S. coelicolor* produced aerial hyphae after 48 h of cultivation, fluorescent ParB-eGFP foci were clearly observed in the cells (Figure [6A](#F6){ref-type="fig"}). However, no obvious focus was detected in Δ*SccobB1* especially in its aerial hyphae (Figure [6B](#F6){ref-type="fig"}), indicating that the ParB segregation complex had not formed in Δ*SccobB1* cells. ParB segregation foci can be visibly observed mainly in aerial hyphae and also in vegetative hyphae ([@B16],[@B43]). To avoid missing the segregation foci in Δ*SccobB1* cells, we monitored the fluorescence signal for a relatively long period to cover the growth stages from vegetative hyphae to sporulation (i.e. the growth stages from 24 to 72 h). Nevertheless, foci were not detected in Δ*SccobB1* at any of these observation points ([Supplementary Figure S9](#sup1){ref-type="supplementary-material"}). On the other hand, ParB segregation foci were observed in both Δ*SccobB2* (Figure [6C](#F6){ref-type="fig"}) and Δ*Scpat* (Figure [6D](#F6){ref-type="fig"}), and the focus intensities were similar to those in wild-type *S. coelicolor* (Figure [6F](#F6){ref-type="fig"}). The expression level of ParB-eGFP was checked in Δ*SccobB1*, and we confirmed that it was not significantly different from that in other cells ([Supplementary Figure S10](#sup1){ref-type="supplementary-material"}). Taken together, these findings are consistent with the *in vitro* ParB-*parS* binding results, suggesting that *Sc*CobB1 plays a dominant regulatory role in the formation of ParB segregation complexes *in vivo*.

![Deletion of *SccobB1* represses the formation of ParB segregation complexes. The formation of ParB segregation complexes was analysed by fluorescence microscopy in wild-type (**A**), Δ*SccobB1* (**B**), Δ*SccobB2* (**C**), Δ*Scpat* (**D**) and Δ*SccobB1* (*parB^K183R^*) (**E**) cells after a 48-h cultivation on MS solid medium. Cell wall staining analyses (red) indicate that these cells were developed the aerial hyphae during this time, probably after aerial hyphae elongation but before spore maturation ([@B53]). While few foci were observed at the proximal regions of aerial hyphae and in the vegetative hyphae, ParB-eGFP foci were clearly observed at the distal regions of aerial hyphae. Very few ParB-eGFP foci were detected in Δ*SccobB1* (**B**) compared with other strains. However, obvious foci for ParB^K183R^-eGFP were detected in Δ*SccobB1*, indicating the defects of Δ*SccobB1* in segregation complex formation were restored. The ParB-eGFP (or ParB^K183R^-eGFP) focus intensities were further quantified by measuring the average fluorescence signal for at least 150 cells from each sample (**F**). The values of background-subtracted signal intensities from the 48-h cultivated aerial hyphae were calculated by ImageJ and normalized against the cell numbers. The signal intensity of the wild-type sample was set as 100%. Mean values with standard deviations are presented. All scale bars, 2 μm.](gkaa245fig6){#F6}

We also observed the formation of ParB segregation complexes using different ParB variants, i.e. the acetylated mimic ParB^K183Q^-eGFP, the deacetylated mimic ParB^K183R^-eGFP, and the wild-type ParB-eGFP, in the genetic background of Δ*parB*. The corresponding cell fluorescence was monitored after 48-h cultivation on MS solid agar ([Supplementary Figure S11](#sup1){ref-type="supplementary-material"}). Consistent with our *in vitro* data (Figure [4A](#F4){ref-type="fig"}), ParB^K183R^-eGFP formed foci in the aerial hyphae ([Supplementary Figure S11](#sup1){ref-type="supplementary-material"}) were slightly brighter than those of wild-type ParB-eGFP. In contrast, ParB^K183Q^-eGFP failed to form any visible foci, even after 72 h of cultivation ([Supplementary Figure S11](#sup1){ref-type="supplementary-material"}). In contrast to the absence of ParB-eGFP foci in Δ*SccobB1*, clear foci were detected for ParB^K183R^-eGFP in Δ*SccobB1* (Figure [6E](#F6){ref-type="fig"}, [F](#F6){ref-type="fig"}). This result suggests that the defects of Δ*SccobB1* in segregation complex formation can be restored by the deacetylated mimic ParB, indicating that acetylation regulates chromosome segregation by targeting ParB.

Because chromosome segregation is necessary for proper cell division ([@B16]), we asked whether acetylation regulation affects *S. coelicolor* sporulation. Our scanning electron microscopy analyses indicated that the spores were uneven in size in Δ*SccobB1* ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). Similar results were observed in Δ*parB* in this ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}) and in previous reports ([@B16]). Therefore, chromosomal DNA of these mutant strains was stained with DAPI for further examination by fluorescence microscopy in this study (Figure [7](#F7){ref-type="fig"}). A total of 22.50% of spores were anucleate in Δ*SccobB1* (Figure [7A](#F7){ref-type="fig"}), and 16.25% of spores were anucleate in Δ*parB* (Figure [7B](#F7){ref-type="fig"}). In contrast, the percentages of anucleate spores in wild-type *S. coelicolor*, Δ*SccobB2*, and Δ*Scpat* were apparently lower (\< 2%, Figure [7A](#F7){ref-type="fig"}). These observations confirm that ParB acetylation is involved in sporulation regulation. The proposal was further supported by the measurements of anucleate spores in the *parB* variant strains in which the *parB* gene was replaced by *parB^K183Q^-egfp*, *parB^K183R^-egfp* or *parB-egfp* (Figure [7B](#F7){ref-type="fig"}). Similar to that in Δ*parB*, the abundance of anucleate spores reached up to 18.75% in the acetylated mimic ParB (ParB^K183Q^-eGFP) strain. In contrast, the cells producing ParB^K183R^-eGFP, which mimicked the deacetylated ParB, have many fewer anucleate spores, nearly equal to that of the wild-type ParB-producing strains (ParB-eGFP) (Figure [7B](#F7){ref-type="fig"}). We also compared the sporulation efficiency of Δ*SccobB1* (*parB^K183R^-egfp*) to the Δ*SccobB1* (*parB-egfp*) cells. The data (Figure [7A](#F7){ref-type="fig"}) showed that ParB^K183R^ partially restored the sporulation defects of *SccobB1* mutant (64%), indicating that Lys-183 acetylation in ParB contributed to the cell sporulation regulation. Taken together, the fluorescence microscopy results suggest that dysfunction in ParB acetylation leads to segregation complex formation disturbances and may result in sporulation defects in *S. coelicolor*.

![Exorbitant acetylation of ParB leads to defective cell sporulation in *S. coelicolor*. Cells were harvested after a 96-h cultivation on MS solid medium to analyse their sporulation by fluorescence microscopy. DAPI staining of the chromosome revealed a higher percentage of anucleate spores (indicated with arrows) in Δ*SccobB1* (**A**), Δ*parB* (**B**), and the acetylation mimicking ParB-producing (ParB^K183Q^) strain (**B**) than those in wild-type *S. coelicolor*. Moreover, the sporulation defects in Δ*parB* and Δ*SccobB1* were fully (**B**) or partially (**A**) recovered by the deacetylation mimicking ParB (ParB^K183R^), respectively. The proportions of anucleate spores are shown in the right panels (400 spores calculated each). All scale bars, 2 μm. A model for the regulation of ParB acetylation in *S. coelicolor* is proposed in (**C**). The ParB binding affinity to the centromere-like *parS* sequence is repressed by acetylation, which is absolved by *Sc*CobB1 deacetylation that triggered by the proper upstream signals (e.g. nutrition depletion). The exorbitant acetylation due to the dysfunction of *Sc*CobB1 impedes the formation of chromosome segregation complexes and may lead to the generation of anucleate spores. Red star, acetylation at Lys-183 of ParB; orange helical line, *parS*; small green oval, *S. coelicolor* chromosome.](gkaa245fig7){#F7}

DISCUSSION {#SEC4}
==========

An increasing number of acetylation proteins have been characterized experimentally in recent years, e.g. acetyl-CoA synthetase ([@B44]), glutamine synthetase ([@B45]), isocitrate lyase ([@B23]) and DNA-binding protein Alba ([@B46]). However, most of these proteins are involved in cell metabolism or gene transcription. To the best of our knowledge, no study has reported that protein deacetylation facilitates chromosome segregation. Here, we present our analyses of a DNA-partitioning protein, ParB, whose activity is positively regulated by the sirtuin-like deacetylase *Sc*CobB1 (Figure [7C](#F7){ref-type="fig"}). Deacetylation at Lys-183 of the HTH DNA-binding motif increases the ability of ParB to bind the centromere sequence, thereby activating ParB complex formation and facilitating cell sporulation (Figure [7C](#F7){ref-type="fig"}).

Transcriptional regulation of the *parAB* operon has been reported, and the *parB* gene is transiently upregulated by its second promoter, *parABp~2~* ([@B18]). However, recent *S. coelicolor* transcriptome analyses revealed that total *parB* transcription is generally invariable throughout the cell cycle ([@B47]), implying that other regulatory mechanism(s) might be involved in chromosome segregation. The acetylation of ParB described here adds another layer to the elaborate regulation of chromosome segregation. Both western blot (Figures [1C](#F1){ref-type="fig"}) and ParB segregation complex formation (Figures [6](#F6){ref-type="fig"}) analyses show that deacetylation activates ParB once the sporulation phase is entered (an approximately 48-h cultivation on MS agar, Figures [1](#F1){ref-type="fig"} and [6](#F6){ref-type="fig"}). The cell wall staining results (Figure [6](#F6){ref-type="fig"}) suggest that *S. coelicolor* developed aerial hyphae after the 48-h cultivation, and a ladder of uniformly spaced septa interspersed with chromosome segregation foci was observed. An aberrant highly acetylated ParB resulting from deletion of the *ScCobB1* gene represses segregation complex formation (Figure [6](#F6){ref-type="fig"}) and leads to defective cell sporulation (Figure [7](#F7){ref-type="fig"}).

While the cellular signals of *parB* transcriptional regulation remain elusive, cells sense the nutrient status to dynamically regulate cellular acetylation ([@B23]). When glucose (or acetyl-CoA) is available, the cellular acetylation level is normally high, and cellular acetylation decreases after glucose is depleted ([@B23],[@B48]). Interestingly, the initiation of cell sporulation is often triggered by nutritional downshift in *Streptomyces* ([@B49],[@B50]). Hence, the diminishment in cell nutrients likely serves as an environmental signal ([@B51]) to increase ParB DNA-binding activity by deacetylation right before sporulation. Moreover, considering that ParB acetylation remains high during vegetative growth phase (Figure [1C](#F1){ref-type="fig"}), one plausible proposal is that inhibition of ParB may prevent interference by such large protein-DNA complexes on other DNA processes such as transcription. Nevertheless, more studies need to be executed to test these hypotheses. Our ParB work here provides evidence of an intimate connection between acetylation regulation and chromosome segregation.

Lys-183 localizes at the tail end of the second α-helix of the HTH motif (Figure [2A](#F2){ref-type="fig"}), which usually recognizes the major groove of the DNA double helix ([@B52]). The EMSA (Figure [3](#F3){ref-type="fig"}) results showed that acetylation of Lys-183 decreases the ParB interaction with *parS*, implying that Lys-183 contributes to the recognition of the *parS* sequence *in vitro*. Alignments of ParB sequences from different bacterial species ([Supplementary Figure S12](#sup1){ref-type="supplementary-material"}) suggest that Lys-183 is conserved among ParB orthologues in most actinobacteria and some representative proteobacteria (e.g. *Mycobacterium*, *Amycolatopsis*, *Nocardia*, and *Agrobacterium*), indicating a possible conserved regulatory role of acetylation in these organisms. However, this lysine residue is not conserved in the ParB orthologues in *Caulobacter* and *Bacillus* ([Supplementary Figure S12](#sup1){ref-type="supplementary-material"}), suggesting that other possible mechanisms might be employed by these microbes.

Both *in vitro* and *in vivo* results suggest that *S. coelicolor* ParB is dominantly regulated by the deacetylase *Sc*CobB1 (Figures [2](#F2){ref-type="fig"}, [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). The *in vitro* data show that *Sc*CobB1 increases the ParB DNA-binding affinity by ∼2-fold (Figure [3](#F3){ref-type="fig"}). Given that the ParB molecules need to bind to \>20 parS sites *in vivo* ([@B15]), we speculate that a very small change in the local ParB concentration could affect the formation of massive segregation complexes. On the other hand, *Sc*Pat is the only GNAT family acetyltransferase in *S. coelicolor* (Figure [2A](#F2){ref-type="fig"}), our observations suggest that it may function only during the early vegetative growth (Figure [5](#F5){ref-type="fig"}). Considering that acetylation by *Sc*Pat is not very efficient both *in vivo* and *in vitro*, we still cannot exclude the possibility that other ParB acetyltransferases exist in the *S. coelicolor* proteome. Meanwhile, *Sc*CobB2 has desuccinylase activity but no deacetylase activity ([@B37]), indicating that it functions as a divergent sirtuin, as in eukaryotic cells ([@B35]). Both our results ([Supplementary Figure S13](#sup1){ref-type="supplementary-material"}) and previous transcriptome data ([@B47]) showed that the transcriptional levels of *SccobB1* and *Scpat* were barely changed on solid culture during the cell cycle. Therefore, the temporal availability of cellular co-factors (i.e. NAD^+^ for *Sc*CobB1 and acetyl-CoA for *Sc*Pat) corresponding to nutrient alterations is likely to play a critical regulatory role in ParB acetylation.
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